Siddiqui Nabeel A, Malik Mushrin, Wijeratne Fernando Ransirini, Sreekantan Nair Archana, Illango Janan, Gor Rajvi, Hamid Pousette
Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus. 2021 May 16;13(5):e15064. doi: 10.7759/cureus.15064.
Research has established a direct link between the plasma level of D-dimer and underlying malignancy. D-dimer has a strong association with the detection and prognosis of several cancers. For these reasons, this literature review aimed to evaluate the usefulness of elevated D-dimer levels in the initial screening of cancer, cancer recurrence surveillance, and for use as a cancer prognostic tool. A search of PubMed up to February 1, 2021, was carried out by reviewers. This literature review includes studies investigating the relationship between pretreatment plasma D-dimer levels and cancer. From the findings, pretreatment D-dimer levels can assist with cancer screening and prognosis assessment. Pretreatment plasma D-dimer levels can function as an effective cancer recurrence control. Elevated pre-treatment plasma D-dimer concentration is valuable in facilitating cancer screening, predicting an augmented risk of cancer recurrence, and anticipating a worse cancer prognosis.
研究已证实血浆D - 二聚体水平与潜在恶性肿瘤之间存在直接联系。D - 二聚体与多种癌症的检测及预后密切相关。基于这些原因,本综述旨在评估D - 二聚体水平升高在癌症初筛、癌症复发监测以及作为癌症预后工具方面的实用性。评审人员检索了截至2021年2月1日的PubMed数据库。本综述纳入了研究治疗前血浆D - 二聚体水平与癌症关系的研究。研究结果表明,治疗前D - 二聚体水平有助于癌症筛查和预后评估。治疗前血浆D - 二聚体水平可作为有效的癌症复发控制指标。治疗前血浆D - 二聚体浓度升高对于促进癌症筛查、预测癌症复发风险增加以及预示癌症预后较差具有重要价值。